Cargando…

Development and validation of a live birth prediction model for expected poor ovarian response patients during IVF/ICSI

BACKGROUND: A number of live birth predictive model during assisted reproductive technology treatment have been available in recent years, but few targeted evaluating the chances of live birth in poor ovarian response(POR) patients. The aim of this study was to develop a nomogram based on POSEIDON c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Xiaoyun, Zhang, Yunian, Zhu, Yuejie, Wang, Peng, Wang, Zhihui, Liu, Chen, Zhang, Manli, La, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927003/
https://www.ncbi.nlm.nih.gov/pubmed/36798666
http://dx.doi.org/10.3389/fendo.2023.1027805
Descripción
Sumario:BACKGROUND: A number of live birth predictive model during assisted reproductive technology treatment have been available in recent years, but few targeted evaluating the chances of live birth in poor ovarian response(POR) patients. The aim of this study was to develop a nomogram based on POSEIDON criteria to predict live birth in patients with expected POR. METHODS: This retrospective cohort study using clinical data from 657 patients in POSEIDON Groups 3 and 4 (antral follicle count [AFC] ≤5 and AMH <1.2 ng/ml) in the Center for Reproductive Medicine, First Affiliated Hospital of Xinjiang Medical University, and Construction a nomogram model t RESULTS: Among 657 expected POR patients, 111 (16.89%) had live births, and 546 (83.11%) did not have live births. These were divided into a training set(n=438) and a validation set (n=219). Multivariate logistic regression analysis showed that the age (OR = 0.91, 95% CI: 0.86–0.97), BMI (OR = 1.98, 95% CI: 1.09–3.67), AMH (OR = 3.48, 95% CI: 1.45–8.51), normal fertilized oocytes (OR = 1.40, 95% CI: 1.21–1.63), and the basal FSH (OR = 0.89, 95% CI: 0.80–0.98) of the female were independent factors predicting live birth in patients with expected POR. Then, an individualized nomogram prediction model was built from these five factors. The area under the ROC curve of the live birth prediction model was 0.820 in the training set and 0.879 in the validation set. CONCLUSION: We have developed a nomogram combining clinical and laboratory factors to predict the probability of live birth in patients with an expected POR during IVF/ICSI, which can helpful for clinician in decision-making. However, the data comes from the same center, needs a prospective multicenter study for further in-depth evaluation and validation of this prediction model.